Growth Metrics

Envoy Medical (COCHW) Short term Debt (2021 - 2023)

Envoy Medical recorded quarterly Short term Debt of $311000.0 in Q4 2023, up 36.4% quarter-over-quarter from $228000.0 in Q3 2023, and down 7.16% year-over-year from $335000.0 in Q4 2022.

Envoy Medical's Short term Debt history runs 3 years deep, the most recent figure standing at $311000.0 for Q4 2023.

  • In Q4 2023, Short term Debt fell 7.16% year-over-year to $311000.0; the TTM figure through Dec 2023 stood at $311000.0 (down 7.16% YoY), while the FY2023 annual figure was $311000.0, down 7.16% from the prior year.
  • Short term Debt came in at $311000.0 for Q4 2023 at Envoy Medical, up from $228000.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $335000.0 in Q4 2022 to a low of $13803.0 in Q1 2021.
  • A 3-year average of $214676.6 and a median of $228000.0 in 2023 frame the typical range for Short term Debt.
  • On a YoY basis, Short term Debt climbed as much as 7.16% in 2023 and fell as far as 7.16% in 2023.
  • Envoy Medical's Short term Debt stood at $185580.0 in 2021, then soared by 80.52% to $335000.0 in 2022, then dropped by 7.16% to $311000.0 in 2023.
  • According to Business Quant data, Short term Debt over the past three periods registered $311000.0, $228000.0, and $335000.0 for Q4 2023, Q3 2023, and Q4 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Envoy Medical - - -274,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 311,000.00
Sep 30, 2023 228,000.00
Dec 31, 2022 335,000.00
Jun 30, 2021 185,580.00
Mar 31, 2021 13,803.00